65184 Federal Register / Vol. 88, No. 182 / Thursday, September 21, 2023 / Notices 

Drive, Room 6164, Bethesda, MD 20892, 

(301) 435–1044, chenhui@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: September 15, 2023. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2023–20437 Filed 9–20–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Human Genome Research 

Institute; Notice of Closed Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Human 

Genome Research Institute Special Emphasis 

Panel; K99–U24–R13 SEP. 

Date: November 3, 2023. 

Time: 2:30 p.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

National Human Genome Research Institute, 

6700B Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Sarah Jo Wheelan, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, National Human Genome Research 

Institute, National Institutes of Health, 6700B 

Rockledge Drive, MSC 6908, Bethesda, MD 

20892, (301) 402–8823, wheelansj@nih.gov. 

Name of Committee: National Human 

Genome Research Institute Special Emphasis 

Panel SEP–1 K99 HG013541–01 Member 

Conflict. 

Date: November 3, 2023. 

Time: 6:15 p.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

National Human Genome Research Institute, 

6700B Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Sarah Jo Wheelan, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, National Human Genome Research 

Institute, National Institutes of Health, 6700B 

Rockledge Drive, MSC 6908, Bethesda, MD 

20892, (301) 402–8823, wheelansj@nih.gov. 

Name of Committee: National Human 

Genome Research Institute Special Emphasis 

Panel; Diversity Centers. 

Date: November 16, 2023. 

Time: 11:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

National Human Genome Research Institute, 

6700B Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Rudy O. Pozzatti, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, National Human Genome Research 

Institute, National Institutes of Health, 6700B 

Rockledge Drive, MSC 6908, Bethesda, MD 

20892, (301) 402–8739, pozzattr@

mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.172, Human Genome 

Research, National Institutes of Health, HHS) 

Dated: September 18, 2023. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2023–20490 Filed 9–20–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, And Blood 

Institute; Notice of Closed Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Heart, Lung, and 

Blood Initial Review Group; NHLBI 

Mentored Transition to Independence Study 

Section. 

Date: November 16–17, 2023. 

Time: 8:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Canopy by Hilton, Washington, 

DC, Bethesda North, 940 Rose Avenue, North 

Bethesda, MD 20892 (Hybrid Meeting). 

Contact Person: Giuseppe Pintucci, Ph.D., 

Scientific Review Officer, Office of Scientific 

Review/DERA, National Heart, Lung, and 

Blood Institute, National Institutes of Health, 

6705 Rockledge Drive, Room 205–H, 

Bethesda, MD 20892, (301) 827–7969, 

Pintuccig@nhlbi.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.233, National Center for 

Sleep Disorders Research; 93.837, Heart and 

Vascular Diseases Research; 93.838, Lung 

Diseases Research; 93.839, Blood Diseases 

and Resources Research, National Institutes 

of Health, HHS) 

Dated: September 18, 2023. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2023–20492 Filed 9–20–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Notice of Diabetes Mellitus Interagency 

Coordinating Committee Meeting 

AGENCY: National Institutes of Health, 

HHS. 

ACTION: Notice. 

SUMMARY: The Diabetes Mellitus 

Interagency Coordinating Committee 

(DMICC) will hold a meeting on 

November 16, 2023. The topic for this 

meeting will be ‘‘The Application of 

Digital Health Technology to Type 2 

Diabetes Management: Current Status, 

Research Gaps, and Opportunities’’. The 

meeting is open to the public. 

DATES: The meeting will be held on 

November 16, 2023 from 12:00 p.m. to 

4:00 p.m. EST. 

ADDRESSES: The meeting will be held 

via the Zoom online video conferencing 

platform. For details, and to register, 

please contact dmicc@mail.nih.gov. 

FOR FURTHER INFORMATION CONTACT: For 

further information concerning this 

meeting, including a draft agenda, 

which will be posted when available, 

see the DMICC website, 

www.diabetescommittee.gov, or contact 

Dr. William Cefalu, Executive Secretary 

of the Diabetes Mellitus Interagency 

Coordinating Committee, National 

Institute of Diabetes and Digestive and 

Kidney Diseases, 6707 Democracy 

Boulevard, Democracy 2, Room 6037, 

Bethesda, MD 20892, telephone: 301– 

435–1011; email: dmicc@mail.nih.gov. 

SUPPLEMENTARY INFORMATION: In 

accordance with 42 U.S. Code 285c–3, 

the DMICC, chaired by the National 

Institute of Diabetes and Digestive and 

Kidney Diseases (NIDDK) comprising 

members of the Department of Health 

and Human Services and other federal 

agencies that support diabetes-related 


ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 88, No. 182 / Thursday, September 21, 2023 / Notices 65185 

activities, facilitates cooperation, 

communication, and collaboration on 

diabetes among government entities. 

DMICC meetings, held several times a 

year, provide an opportunity for 

Committee members to learn about and 

discuss current and future diabetes 

programs in DMICC member 

organizations and to identify 

opportunities for collaboration. The 

November 16, 2023 DMICC meeting will 

focus on ‘‘The Application of Digital 

Health Technology to Type 2 Diabetes 

Management: Current Status, Research 

Gaps, and Opportunities.’’ 

Any member of the public interested 

in presenting oral comments to the 

Committee should notify the contact 

person listed on this notice at least 5 

days in advance of the meeting. 

Interested individuals and 

representatives or organizations should 

submit a letter of intent, a brief 

description of the organization 

represented, and a written copy of their 

oral presentation in advance of the 

meeting. Only one representative of an 

organization will be allowed to present; 

oral comments and presentations will be 

limited to a maximum of 5 minutes. 

Printed and electronic copies are 

requested for the record. In addition, 

any interested person may file written 

comments with the Committee by 

forwarding their statement to the 

contact person listed on this notice. The 

statement should include the name, 

address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

Because of time constraints for the 

meeting, oral comments will be allowed 

on a first-come, first-serve basis. 

Members of the public who would 

like to receive email notification about 

future DMICC meetings should register 

for the listserv available on the DMICC 

website, www.diabetescommittee.gov. 

William T. Cefalu, 

Director, Division of Diabetes, Endocrinology, 

and Metabolic Diseases, National Institute of 

Diabetes and Digestive and Kidney Diseases, 

and Metabolic Diseases, National Institutes 

of Health. 

[FR Doc. 2023–20390 Filed 9–20–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Fiscal Year (FY) 2023 Notice of 

Supplemental Funding Opportunity 

AGENCY: Substance Abuse and Mental 

Health Services Administration, 

Department of Health and Human 

Services (HHS). 

ACTION: Notice of intent to award 

supplemental funding. 

SUMMARY: This notice is to inform the 

public that the Substance Abuse and 

Mental Health Services Administration 

(SAMHSA) is proposing to provide oneyear supplemental funding in FY 2023 

to three Hawaii grant programs to 

support Maui residents in the aftermath 

of the Maui wildfires. The Hawaii State 

Department of Health, the recipient for 

Certified Community Behavioral Health 

Clinics Planning, Development, and 

Implementation (CCBHC–PDI), Grants 

for Expansion and Sustainability of the 

Comprehensive Community Mental 

Health Services for Children with 

Serious Emotional Disturbances 

Program (CMHI), and Community 

Mental Health Services Block Grant 

(MHBG) will be offered a total of 

$2,765,556 in supplemental funding 

since they are the only recipient 

providing or able to provide services to 

Maui residents. 

FOR FURTHER INFORMATION CONTACT: 

Tison Thomas, Deputy Director, Center 

for Mental Health Services/SAMHSA, 

Tison.thomas@samhsa.hhs.gov; 202– 

853–5282. 

SUPPLEMENTARY INFORMATION: 

Funding Opportunity Title: FY 2022 

Certified Community Behavioral Health 

Clinics Planning, Development, and 

Implementation Grants (CCBHC–PDI), 

SM–22–022; FY 2023 Community 

Mental Health Services Block Grant 

(MHBG); FY 2020 Grants for Expansion 

and Sustainability of the 

Comprehensive Community Mental 

Health Services for Children with 

Serious Emotional Disturbances (CMHI). 

Assistance Listing Number: 93.696— 

CCBHC–PDI; 93.104—CMHI; 93.958— 

MHBG. 

Authority: CCBHC–PDI grants are 

authorized under Section 520A of the 

Public Health Services Act, as amended. 

CMHI grants are authorized under 

Sections 516–565 of the Public Health 

Services Act, as amended. MHBG grants 

are authorized under Section 1920 of 

the Public Health Service Act, as 

amended. 

Justification: Eligibility for this 

supplemental funding is limited to the 

Hawaii State Department of Health as 

the grant recipient for the CCBHC–PDI, 

CMHI and MHBG programs. They are 

the only Hawaii funded recipient within 

these programs and are providing or 

able to provide services to Maui 

residents. This supplemental funding 

will be used to address the behavioral 

health needs of Maui residents in the 

aftermath of the Maui wildfires. This is 

not a formal request for application. 

Assistance will only be provided to the 

Hawaii State Department of Health 

based on the receipt of a satisfactory 

application and associated budget. 

Dated: September 15, 2023. 

Ann Ferrero, 

Public Health Analyst. 

[FR Doc. 2023–20432 Filed 9–20–23; 8:45 am] 

BILLING CODE 4162–20–P 

DEPARTMENT OF HOMELAND 

SECURITY 

Coast Guard 

[Docket No. USCG–2010–0164] 

National Boating Safety Advisory 

Committee; October 17, 2023 Virtual 

Meeting 

AGENCY: U.S. Coast Guard, Department 

of Homeland Security. 

ACTION: Notice of Federal advisory 

committee virtual meeting. 

SUMMARY: The National Boating Safety 

Advisory Committee (Committee) and 

its Subcommittees will meet virtually to 

discuss matters relating to national 

boating safety. The virtual meeting will 

be open to the public. 

DATES: 

Meeting: The Committee and its 

Subcommittees will meet on Tuesday, 

October 17, 2023, from noon until 4 

p.m. Eastern Standard Time (EST). This 

virtual meeting may adjourn early if the 

Committee has completed its business. 

Comments and supporting 

documentation: To ensure your 

comments are received by Committee 

members before the virtual meeting, 

submit your written comments no later 

than October 11, 2023. 

ADDRESSES: To join the virtual meeting 

or to request special accommodations, 

contact the individual listed in the FOR

FURTHER INFORMATION CONTACT section 

no later than 1 p.m. EST on October 16, 

2023. The number of virtual lines are 

limited and will be available on a firstcome, first-served basis. 

Pre-registration information: Preregistration is required for attending this 

virtual meeting. You must request 

attendance by contacting the individual 

listed in the FOR FURTHER INFORMATION

CONTACT section of this notice. You will 

receive a response with attendance 

instructions. 

The National Boating Safety Advisory 

Committee is committed to ensuring all 

participants have equal access 

regardless of disability status. If you 

require reasonable accommodation due 


ddrumheller on DSK120RN23PROD with NOTICES1